H1-0 and breast cancer: We also analyzed the levels of histone H1 isoforms in the context of tumor recurrence by profiling 37 breast cancer samples belonging to the triple-negative subtype, of which 19 with and 18 without relapse three years after treatment, matched for clinical features and adjuvant chemotherapy.